These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 28402724)
1. Carbapenem-resistant Enterobacteriaceae: What we know and what we need to know. van Duin D Virulence; 2017 May; 8(4):379-382. PubMed ID: 28402724 [No Abstract] [Full Text] [Related]
6. Occurrence of carbapenemase-producing Enterobacteriaceae in Togo, West Africa. Dossim S; Bonnin RA; Salou M; Tanga K; Godonou V; Dagnra AY; Prince David M; Naas T; Dortet L Int J Antimicrob Agents; 2019 Apr; 53(4):530-532. PubMed ID: 30476571 [No Abstract] [Full Text] [Related]
7. Treating complicated carbapenem-resistant enterobacteriaceae infections with ceftazidime/avibactam: a retrospective study with molecular strain characterisation. Krapp F; Grant JL; Sutton SH; Ozer EA; Barr VO Int J Antimicrob Agents; 2017 Jun; 49(6):770-773. PubMed ID: 28389354 [TBL] [Abstract][Full Text] [Related]
8. Prevalence of Invasive Infections Due to Carbapenem-Resistant Enterobacteriaceae among Adult Patients in U.S. Hospitals. Lodise T; Ye MJ; Zhao Q Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559271 [TBL] [Abstract][Full Text] [Related]
10. Staggering the administration of polymyxin B and meropenem in time-kill against carbapenem-resistant Enterobacteriaceae exhibiting a wide range of meropenem MICs. Kulengowski B; Clark JA; Burgess DS Diagn Microbiol Infect Dis; 2019 Mar; 93(3):261-264. PubMed ID: 30344066 [TBL] [Abstract][Full Text] [Related]
11. Direct determination of carbapenem-resistant Enterobacteriaceae and Pseudomonas aeruginosa from positive blood cultures using laser scattering technology. Idelevich EA; Hoy M; Knaack D; Görlich D; Peters G; Borowski M; Becker K Int J Antimicrob Agents; 2018 Feb; 51(2):221-226. PubMed ID: 29111432 [TBL] [Abstract][Full Text] [Related]
12. Pitfalls of defining combination therapy for carbapenem-resistant Enterobacteriaceae in observational studies. Giacobbe DR; Maraolo AE; Viscoli C Eur J Clin Microbiol Infect Dis; 2017 Oct; 36(10):1707-1709. PubMed ID: 28528405 [No Abstract] [Full Text] [Related]
13. Leveraging antimicrobial stewardship into improving rates of carbapenem-resistant Enterobacteriaceae. Wong D; Spellberg B Virulence; 2017 May; 8(4):383-390. PubMed ID: 27187821 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of an in-house developed multiplex real-time PCR for the detection of IMP, OXA-23, GES carbapenemases and the transmissible colistin-resistant mcr gene on the BD MAX™ open system. Teo JW; Octavia S; Cheng JW; Lin RT Diagn Microbiol Infect Dis; 2018 Jan; 90(1):67-69. PubMed ID: 29132936 [No Abstract] [Full Text] [Related]
15. Pharmacodynamic and pharmacokinetic considerations in the treatment of critically Ill patients infected with carbapenem-resistant Enterobacteriaceae. Neuner EA; Gallagher JC Virulence; 2017 May; 8(4):440-452. PubMed ID: 27589330 [TBL] [Abstract][Full Text] [Related]
16. Review and mapping of carbapenem-resistant Enterobacteriaceae in Africa: Using diverse data to inform surveillance gaps. Mitgang EA; Hartley DM; Malchione MD; Koch M; Goodman JL Int J Antimicrob Agents; 2018 Sep; 52(3):372-384. PubMed ID: 29864500 [TBL] [Abstract][Full Text] [Related]
17. Use of meropenem in treating carbapenem-resistant Enterobacteriaceae infections. Pascale R; Giannella M; Bartoletti M; Viale P; Pea F Expert Rev Anti Infect Ther; 2019 Oct; 17(10):819-827. PubMed ID: 31559876 [No Abstract] [Full Text] [Related]
18. Update on fosfomycin-modified genes in Enterobacteriaceae. Yang TY; Lu PL; Tseng SP J Microbiol Immunol Infect; 2019 Feb; 52(1):9-21. PubMed ID: 29198952 [TBL] [Abstract][Full Text] [Related]
19. [Progress in the diagnosis of carbapenem-resistant Enterobacteriaceae]. Xu X; Qu F Sheng Wu Gong Cheng Xue Bao; 2018 Aug; 34(8):1338-1345. PubMed ID: 30152219 [TBL] [Abstract][Full Text] [Related]
20. Review: Molecular detection of extended spectrum-β-lactamase- and carbapenemase-producing Enterobacteriaceae in a clinical setting. Rood IGH; Li Q Diagn Microbiol Infect Dis; 2017 Nov; 89(3):245-250. PubMed ID: 28865742 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]